SUNNYVALE, Calif. , Jan. 11, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company's Board of Directors, effective January 7, 2018 . Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc. , Surefire Medical, Inc.
SUNNYVALE, Calif. , Jan. 10, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2017 on Tuesday, January 23, 2018 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Company will pay principal in cash and deliver shares for any excess conversion value SUNNYVALE, Calif. , Jan. 3, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has made an irrevocable Net Share Settlement Election with respect to its 3.50% Series A Convertible Senior Notes due February
SUNNYVALE, Calif. , Jan. 3, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at the J.P. Morgan 36th Annual Healthcare Conference on Wednesday, January 10, 2018 at the Westin St. Francis Hotel in San Francisco .
Company Also Modifies Revolving Loan Agreement SUNNYVALE, Calif. , Dec. 21, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it closed a new $40 million term loan with MidCap Financial Trust while concurrently reducing the borrowing facility under its existing revolving
iDMS™ Data Management System Helps Improve Treatment Outcomes and Efficiency by Sharing Patient Data Throughout the Entire Disease Management Period SUNNYVALE, Calif. , Dec. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Heidelberg University Hospital in
Advanced Radiation Therapy Systems Manufactured, Installed and Serviced by Accuray Veterans Help Improve the Lives of Military Personnel who are Diagnosed with Cancer SUNNYVALE, Calif. , Nov. 8, 2017 /PRNewswire/ -- November 11, 2017 marks Veterans Day in the United States , a day to publicly
- Accuray Precision™ Treatment Planning System and CyberKnife System Software Upgrade Enhances Efficiency and Ease-of-Use - Leading Radiation Oncology Providers at Institut Gustave Roussy, Lynn Cancer Institute, Multicare Hospital, Queen Elizabeth Hospital Birmingham, University Clinic for
SUNNYVALE, Calif. , Oct. 24, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first fiscal quarter ended September 30, 2017 . First Quarter Highlights Gross orders increased 11 percent to $55.6 million , net orders were $51.0 million .
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
